| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 13.555 | 34.438 | 48.090 | 60.377 | 58.283 | 20.217 | 19.459 | 26.894 | 31.602 |
| Total Income - EUR | - | 13.556 | 34.439 | 48.091 | 60.378 | 60.351 | 20.218 | 19.459 | 26.894 | 31.607 |
| Total Expenses - EUR | - | 11.254 | 37.657 | 41.486 | 41.869 | 36.913 | 19.091 | 27.679 | 28.689 | 34.004 |
| Gross Profit/Loss - EUR | - | 2.302 | -3.218 | 6.604 | 18.509 | 23.438 | 1.126 | -8.220 | -1.794 | -2.398 |
| Net Profit/Loss - EUR | - | 2.166 | -3.562 | 6.125 | 17.905 | 22.902 | 959 | -8.393 | -2.049 | -2.914 |
| Employees | - | 1 | 4 | 6 | 6 | 5 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Rallumedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 509 | 428 | 350 | 275 | 8.427 | 6.638 | 3.908 | 1.192 |
| Current Assets | - | 6.004 | 5.007 | 9.864 | 24.702 | 31.254 | 20.628 | 12.628 | 11.278 | 11.890 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.966 | 4.616 | 4.168 | 5.243 | 779 | 2.022 | 2.087 | 4.506 | 1.400 |
| Cash | - | 3.038 | 392 | 5.696 | 19.460 | 30.475 | 18.606 | 10.541 | 6.772 | 10.490 |
| Shareholders Funds | - | 2.211 | -3.519 | 2.671 | 17.955 | 29.453 | 19.651 | 11.319 | 9.236 | 5.550 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 3.793 | 9.035 | 7.621 | 7.097 | 2.076 | 9.404 | 7.946 | 5.950 | 7.531 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Rallumedica Srl